Robert Figlin, MD of Samuel Oschin Comprehensive Cancer Institute explains how he stratifies metastatic RCC patients to choose the most appropriate treatments at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Choosing the most appropriate treatment for metastatic RCC patients
